Abacus Bioscience Inc
- Biotech or pharma, therapeutic R&D
Abacus Bioscience has a humanized anti-CD180 agonistic antibody, ABB071, available to partner. This development candidate is highly manufacturable and has excellent in vivo potency.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}